Back
Canonical NF-κB regulator CYLD mutations reinforce RelB mediated disease pathogenesis in Multiple Myeloma
Sarkar, U. A.; Kumar, L.; Basak, S.
2026-02-03
cancer biology
10.64898/2026.02.01.703152
bioRxiv
Show abstract
Withdrawal StatementbioRxiv has withdrawn this manuscript because it was posted without the consent of all authors. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author
Matching journals
●Non-profit
◐University press
○Commercial
The top 12 journals account for 50% of the predicted probability mass.
1
Nature Communications
○
5641 papers in training set
Top 18%
9.9%
Similar papers in this journal
- Accelerated single cell seeding in relapsed multiple myeloma 92%
- Aberrant non-canonical NF-kappaB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma 92%
- Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical Outcomes 91%
2
Leukemia
○
42 papers in training set
Top 0.2%
6.3%
Similar papers in this journal
- Multiple Myeloma DREAM Challenge Reveals Epigenetic Regulator PHF19 As Marker of Aggressive Disease 92%
- Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting 90%
- Resistance to decitabine and 5-azacytidine emerges from adaptive responses of the pyrimidine metabolism network 90%
3
eLife
●
5828 papers in training set
Top 19%
6.3%
Similar papers in this journal
- The Fatty Acid Binding Protein Family Represents a Novel Target in Multiple Myeloma 90%
- Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia 90%
- Prolonged T-cell activation and long COVID symptoms independently associate with severe disease at 3 months in a UK cohort of hospitalized COVID-19 patients 89%
4
Blood
●
74 papers in training set
Top 0.3%
6.3%
Similar papers in this journal
- Systems medicine dissection of chromosome 1q amplification reveals oncogenic regulatory circuits and informs targeted therapy in cancer 92%
- Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B Cell Lymphoma 91%
- Mutant-SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms 91%
50% of probability mass above
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.